SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Clinical trials for SLL (SMALL LYMPHOCYTIC LYMPHOMA) explained in plain language.
Never miss a new study
Get alerted when new SLL (SMALL LYMPHOCYTIC LYMPHOMA) trials appear
Sign up with your email to follow new studies for SLL (SMALL LYMPHOCYTIC LYMPHOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug rocbrutinib takes on pirtobrutinib in blood cancer showdown
Disease control Recruiting nowThis study tests a new drug, rocbrutinib, against another drug, pirtobrutinib, in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whose cancer has returned or stopped responding to treatment. All participants have already tried a type of BTK inh…
Matched conditions: SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Phase: PHASE3 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New pill ZE50-0134 takes on Hard-to-Treat leukemia and lymphoma
Disease control Recruiting nowThis early-stage study is testing a new oral drug called ZE50-0134 in 66 adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or certain low-grade lymphomas that have come back or not responded to prior treatments. The main goal is to check the drug's…
Matched conditions: SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC